A growing number of studies have shown that autophagy exerts paradoxical roles in anti-CRC treatment via multiple signaling pathways, including the inhibition of the PI3K/AKT/mTOR signaling pathway [7]. This evidence concerns the gene AKT1 and colorectal carcinoma.